The disclosure intimates the schedule of upcoming analyst and institutional investor meetings for Sun Pharmaceutical Industries Limited.
The event type is a series of meetings, including group sessions and one-on-one interactions, organized by brokerages.
Meeting 1: Date: 10-Aug-26. Organized by: Nirmal Bang Institutional Equities. Event Theme: Business Outlook & Leading Through Volatility. Venue: Mumbai. Type: Physical. Format: Group & One-on-one.
The stated purpose of these meetings is for general interaction and discussion; no specific financial period for results discussion is mentioned.
The company has explicitly stated that it will not be disclosing any Unpublished Price Sensitive Information (UPSI) at these meetings.
The disclosure is signed by Mr. Anoop Deshpande, Company Secretary and Compliance Officer.
Additional Notes Section
The disclosure is a mandatory intimation made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
No financial data, presentation decks, transcripts, or recordings were mentioned as being available or attached to this announcement.
The company notes that the schedule is subject to change due to exigencies.
